Companies To Watch: Investing showdown - Alibaba, Genus, Pfizer, and Pop Mart compete for the crown

It’s time for The Breakfast Show’s monthly stock face-off. Four picks, three bull cases each, and one clear winner by month-end.

Dan Koh’s betting on Alibaba, banking on its AI-and-chips transformation. Emaad Akhtar’s countering with Pfizer, and its promising pharma pipeline. Ryan Huang’s going with Genus, turning bull genetics into a billion-dollar business. And Audrey Siek’s pick? Pop Mart, riding Asia’s collectible craze.

From tech to pharma, agriculture to pop culture, they break down the catalysts that could send these stocks higher, and find out whose pick takes the crown when the dust settles.

See omnystudio.com/listener for privacy information.